Skip to main content
. 2022 Aug 12;12(8):1946. doi: 10.3390/diagnostics12081946

Table 2.

Echocardiographic parameters at baseline in the entire study population and divided in two subgroups according to the occurrence of MACE.

Population MACE
(n = 9)
Without MACE
(n = 41)
p Value
2D LVEDV (mL) 102.74 ± 24.54 118.55 ± 29.43 99.26 ± 22.27 0.031
2D LVEDV (mL/mp) 53.97 ± 12.6 64.18 ± 13.91 51.75 ± 11.28 0.06
2D LVESV (mL) 59.72 ± 20.91 81.77 ± 25.36 54.87 ± 16.55 0.013
2D LVESV (mL/mp) 59.72 ± 20.91 81.77 ± 25.36 54.87 ± 16.55 0.013
2D EF (%) 41.94 ± 7.07 32.88 ± 5.79 43 ± 6.6 <0.0001
3D LVEDV (mL) 113.46 ± 24.46 127.66 ± 28.48 110.34 ± 22.7 0.053
3D LVEDV (ml/mp) 59.77 ± 13.02 69.24 ± 13.45 57.69 ± 12.36 0.016
3D LVESV (mL) 65.74 ± 21.15 87 ± 25.91 61.07 ± 17.02 0.001
3D LVESV (mL/mp) 34.67 ± 11.34 47.13 ± 12.73 31.93 ± 9.08 <0.0001
3D LVEF (%) 40.02 ± 8.05 33 ± 6.55 45.24 ± 6.5 <0.0001
LV GLS −12.93 ± 2.2 −8.85 ± 1.58 −13.8 ± 2.8 <0.0001
LV mechanical dispersion 72.57 ± 26.49 93.11 ± 29.36 68.06 ± 23.9 0.009
E/e’ (LV filling pressure) 8.2 ± 2.92 10.68 ± 2.01 7.59 ± 2.03 <0.0001
Myocardial work indices
LV GWI, mmHg% 1089.66 ± 318.97 1167.07 ± 295.67 737 ± 124.24 <0.0001
LV GCW, mmHg% 1430.54 ± 325.37 1499.68 ± 304.01 1115.55 ± 224.06 0.001
LV GWW, mmHg% 193.14 ± 105.84 172.75 ± 96.3 286 ± 102.07 0.003
LV GWE, % 86.12 ± 6.55 87.95 ± 5.53 77.77 ± 3.8 <0.0001